Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (35)

2023

  1. Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 397-400

2022

  1. At-admission HbA1c levels in hospitalized COVID-19 participants with and without known diabetes

    Clinica Chimica Acta, Vol. 532, pp. 188-192

  2. The oxyhaemoglobin dissociation curve is generally left-shifted in COVID-19 patients at admission to hospital, and this is associated with lower mortality

    British Journal of Haematology, Vol. 199, Núm. 3, pp. 332-338

2021

  1. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis

    Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 465-478

  2. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  3. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

2019

  1. Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1023-1030

2018

  1. Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes

    Diabetes Research and Clinical Practice, Vol. 142, pp. 100-109

2017

  1. Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance

    Clinical Biochemistry, Vol. 50, Núm. 3, pp. 110-115

2016

  1. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status

    Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578

2015

  1. CD26 Expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis

    PLoS ONE, Vol. 10, Núm. 7

  2. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

  3. Influence of the glycation gap on the diagnosis of type 2 diabetes

    Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459

  4. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma

    Clinica Chimica Acta

2011

  1. Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells

    Cellular Immunology, Vol. 271, Núm. 2, pp. 319-328

  2. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

  3. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity

    Journal of Child Neurology

2010

  1. Levels of leptin, insulin, IGF-I, IGFBP-3, IL-6 and IL-8 in sera of patients with muscular dystrophy and mitochondrial encephalomyopathy

    Journal of Pediatric Neurology, Vol. 8, Núm. 4, pp. 375-379

2009

  1. Translating the A1C assay into estimated average glucose values

    Diabetes Care

2008

  1. Therapeutic criteria in communicating childhood hydrocephalus

    Journal of Neurosurgical Sciences, Vol. 52, Núm. 1, pp. 17-21